about
Hepatitis-related hepatocellular carcinoma: Insights into cytokine gene polymorphismsTh1/Th2 cytokines and their genotypes as predictors of hepatitis B virus related hepatocellular carcinomaInhibition of Intrahepatic Gamma Interferon Production by Hepatitis C Virus Nonstructural Protein 5A in Transgenic MiceAnalysis of successful immune responses in persons infected with hepatitis C virusInducible nitric oxide synthase is critical for immune-mediated liver injury in miceInflammatory cascades driven by tumor necrosis factor-alpha play a major role in the progression of acute liver failure and its neurological complicationsLack of evidence to support the association of a single IL28B genotype SNP rs12979860 with the HTLV-1 clinical outcomes and proviral load.Inhibition of Fas/FasL mRNA expression and TNF-alpha release in concanavalin A-induced liver injury in mice by bicyclolAntigen-specific immune responses and liver histology in HIV and hepatitis C coinfection.Single-dose infliximab in hepatitis C genotype 1 treatment-naive patients with high serum tumour necrosis factor-alpha does not influence the efficacy of pegylated interferon alpha-2b/ribavirin therapy.Polymorphisms of interleukin-1R receptor antagonist genes in patients with chronic hepatitis B in Iran.Non invasive fibrosis biomarkers reduce but not substitute the need for liver biopsy.Activation of hepatic stellate cells after phagocytosis of lymphocytes: A novel pathway of fibrogenesis.Antioxidant and immunomodulatory effects of Viusid in patients with chronic hepatitis C.Relationship between TNF-<alpha> gene promoter polymorphisms and outcomes of hepatitis B virus infections: a meta-analysis.Biology and significance of T-cell apoptosis in the liver.Association of TNF-α Promoter Polymorphism with HBV Associated Disease Outcome Among HBV Infected Patients from Orissa, Southern Part of East India.Opposing roles of STAT1 and STAT3 in T cell-mediated hepatitis: regulation by SOCS.Relationship between serum cytokine levels and histopathological changes of liver in patients with hepatitis B.Association of polymorphism of tumor necrosis factor-alpha gene promoter region with outcome of hepatitis B virus infection.HIV-1 coinfection profoundly alters intrahepatic chemokine but not inflammatory cytokine profiles in HCV-infected subjects.Hepatoprotective Effects of Total Triterpenoids and Total Flavonoids from Vitis vinifera L against Immunological Liver Injury in Mice.Investigation of Transforming Growth Factor-β1 Gene Polymorphisms Among Iranian Patients With Chronic Hepatitis C.Interferon-γ polymorphism and hepatocellular carcinoma susceptibility: a meta analysis.Distinct immunoregulatory cytokine pattern in Egyptian patients with occult Hepatitis C infection and unexplained persistently elevated liver transaminasesPolymorphisms of interleukin-1B and interleukin-1 receptor antagonist genes in patients with chronic hepatitis B.Tumor necrosis factor-alpha 308.2 polymorphism is associated with advanced hepatic fibrosis and higher risk for hepatocellular carcinoma.Effects of interleukin 10 polymorphisms on the development of hepatitis B virus infection: a systemic review and meta-analysis.Intrahepatic and peripheral T-cell responses in genotype 1b hepatitis C virus-infected patients with persistently normal and elevated aminotransferase levels.Tumor necrosis factor-alpha -308G/A polymorphism and risk of hepatocellular carcinoma in hepatitis C virus-infected patientsInterferon Gamma Gene Polymorphism (+874 T > A) and Chronic Hepatitis B in the Population of Gorgan, North-Eastern IranCD4+ primary T cells expressing HCV-core protein upregulate Foxp3 and IL-10, suppressing CD4 and CD8 T cells.Genetic polymorphisms -137 (rs187238) and -607 (rs1946518) in the interleukin-18 promoter may not be associated with development of hepatocellular carcinoma.Association of TNF-α Gene Polymorphisms with Production of Protein and Susceptibility to Chronic Hepatitis B Infection in the South East Iranian Population.Correlation between the suppressor of cytokine signaling-1 and 3 and hepatitis B virus: possible roles in the resistance to interferon treatment.SOCS3 genetic variants and promoter hypermethylation in patients with chronic hepatitis B.The relationship between tumor necrosis factor-α polymorphisms and hepatitis C virus infection: a systematic review and meta-analysis.Leptin deficiency, not obesity, protects mice from Con A-induced hepatitis.Leptin receptor isoforms mRNA expression in peripheral blood mononuclear cells from patients with chronic viral hepatitis.Soluble inflammatory markers as predictors of virological response in patients with chronic hepatitis C virus infection treated with interferon-α plus ribavirin.
P2860
Q26738545-A4CBA2B8-FCAA-468D-B62D-9177D29343A4Q26863635-A51AB87A-A543-4B1E-933A-CEDB28893466Q27489517-49150A94-7674-4FB7-8C4A-608618EB8EF9Q27860698-011A2833-D432-4136-8639-B129AFDEA958Q28350110-9D8FAC61-F193-4CA7-A857-F8C6BA1B1C8DQ28485217-7E254F8D-BB62-48FB-8A72-70484A8C2911Q31109635-CAC7468D-8D0D-4E14-825E-CBE18B2A40DBQ33203621-2B9DD5A8-7043-4B81-9FB1-445012BA00EDQ33730915-F1E8844E-7593-49CB-98E4-9B7D01CF1DB6Q33810143-AE2B9F03-F1F0-4771-B893-F6E138C31C9AQ33866195-8634DBE5-B149-424B-B1CD-4734A72AFD90Q33866383-3A9A1600-B247-4232-8AEB-4F32897DFC12Q33893099-D86A36D4-F507-415E-8CCE-009EF39E0CABQ33894202-D86D3668-1727-4FEF-96DC-4C3E53834E14Q33900208-CBEE171A-E069-428C-9296-B92C0D367967Q34546442-84B4B8C1-0C20-467D-875E-DD35D3073CFAQ34825656-1E41E7E6-6AF5-46EB-B0EC-A5D34A557D04Q34826141-2B3D5C61-ADF8-4F32-9B2C-EF3E728FB8DDQ35045622-32D1F80D-F454-43A0-A64E-48713781000CQ35059739-731A5A51-9B98-4C98-8684-BC0BC916F6BFQ35091404-1879B5A6-0CD2-4F29-9D84-249510CF31DBQ35676011-5827EDCB-039C-4AEB-9FC3-643D54B6DFA6Q35764246-B6745250-0B2B-4728-9844-24A56E08C5DFQ35791992-405D4329-3758-42C2-BA74-31A5FA720D81Q35964424-53AA0E9B-6A34-482B-A97C-7EF5777676F3Q36065997-90EC03FB-26DB-4184-A78F-8E8AD4FEFB49Q36143638-7099796C-F8FF-438D-BB3C-ECDE8DF7FD84Q36182597-5E294112-0FE7-46E2-B424-D9BB4B04C92EQ36491605-83D23A62-1C4E-46C3-9435-D7AF81AB1357Q37183637-FB425253-26D5-4F6A-8F64-2C88703390B6Q37367659-35ABB8E4-3D77-4F8F-BE04-EF6F95AE437EQ37495787-8C3C4EAE-4D83-404C-BF9D-2FDC3CDF7A37Q37522290-A9750CCA-10E1-4E93-8AF6-1DA663166E31Q37547187-1757ED57-A435-43AA-80AD-3073D4A0EB06Q37716483-CA68C6FD-DD54-49CA-A660-92B45BC5AD82Q37725585-5C6522BB-F2DA-49F8-954E-76529F469483Q37919519-283A2F12-7950-4A3F-8BF3-9B041A206938Q38292343-4B0D1515-7630-4EBB-941D-D0270F27A578Q38308234-A52378DB-3E78-43A8-A810-44E3A8A45B9FQ39275394-3F5A7179-6826-4719-AFB5-784D47E5834D
P2860
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Cytokines in viral hepatitis.
@ast
Cytokines in viral hepatitis.
@en
type
label
Cytokines in viral hepatitis.
@ast
Cytokines in viral hepatitis.
@en
prefLabel
Cytokines in viral hepatitis.
@ast
Cytokines in viral hepatitis.
@en
P356
P1476
Cytokines in viral hepatitis.
@en
P2093
P304
P356
10.1055/S-2007-1007107
P577
1999-01-01T00:00:00Z